TSX News -
Bombardier Announces Launch of its New Issuance of Senior Notes due 2032
MONTREAL, May 21, 2024 (GLOBE NEWSWIRE) — Bombardier Inc. (“Bombardier”) today announced that it has launched an offering of US$500 […]
MONTREAL, May 21, 2024 (GLOBE NEWSWIRE) — Bombardier Inc. (“Bombardier”) today announced that it has launched an offering of US$500 […]
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 21, 2024 (GLOBE […]
MIAMI, May 21, 2024 (GLOBE NEWSWIRE) — SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), today announced that the U.S. Food […]
Stellantis to Participate inBernstein 40th Annual Strategic Decisions Conference AMSTERDAM, May 21, 2024 – Carlos Tavares, Stellantis Chief Executive Officer, […]
TORONTO, May 21, 2024 (GLOBE NEWSWIRE) — Xtract One Technologies Inc. (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or […]
LOS ANGELES, May 21, 2024 (GLOBE NEWSWIRE) — BlackLine, Inc. (Nasdaq: BL), today announced that it intends to offer, subject […]
BEIJING, May 21, 2024 (GLOBE NEWSWIRE) — KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading […]
Translational data presented during a late-breaker poster session from a head-to-head study of eblasakimab and dupilumab in a human tissue […]
LAVA-1207 dose escalation progressing in Phase 1/2a trial in prostate cancer, with pembrolizumab combination expected to begin in Q2 2024 […]
MONTVALE, N.J., May 21, 2024 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and […]